BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20534382)

  • 1. Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath.
    Tékus V; Bölcskei K; Kis-Varga A; Dézsi L; Szentirmay E; Visegrády A; Horváth C; Szolcsányi J; Petho G
    Eur J Pharmacol; 2010 Sep; 641(2-3):135-41. PubMed ID: 20534382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the peripheral mediator background of heat injury- and plantar incision-induced drop of the noxious heat threshold in the rat.
    Füredi R; Bölcskei K; Szolcsányi J; Petho G
    Life Sci; 2010 Feb; 86(7-8):244-50. PubMed ID: 20036261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: a novel rat thermal hyperalgesia model.
    Bölcskei K; Horváth D; Szolcsányi J; Petho G
    Eur J Pharmacol; 2007 Jun; 564(1-3):80-7. PubMed ID: 17397823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of analgesics on the plantar incision-induced drop of the noxious heat threshold measured with an increasing-temperature water bath in the rat.
    Füredi R; Bölcskei K; Szolcsányi J; Petho G
    Eur J Pharmacol; 2009 Mar; 605(1-3):63-7. PubMed ID: 19168047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.
    Bölcskei K; Tékus V; Dézsi L; Szolcsányi J; Petho G
    Eur J Pain; 2010 May; 14(5):480-6. PubMed ID: 19800272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.
    Kanai Y; Hara T; Imai A; Sakakibara A
    J Pharm Pharmacol; 2007 May; 59(5):733-8. PubMed ID: 17524240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
    Jhaveri MD; Elmes SJ; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):361-70. PubMed ID: 16045489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
    Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
    Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.
    Kamata Y; Kambe T; Chiba T; Yamamoto K; Kawakami K; Abe K; Taguchi K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of AMG0347, a transient receptor potential type V1 receptor antagonist, and morphine on pain behavior after plantar incision.
    Wu C; Gavva NR; Brennan TJ
    Anesthesiology; 2008 Jun; 108(6):1100-8. PubMed ID: 18497612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
    Gavva NR; Tamir R; Qu Y; Klionsky L; Zhang TJ; Immke D; Wang J; Zhu D; Vanderah TW; Porreca F; Doherty EM; Norman MH; Wild KD; Bannon AW; Louis JC; Treanor JJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):474-84. PubMed ID: 15615864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist.
    Kitagawa Y; Miyai A; Usui K; Hamada Y; Deai K; Wada M; Koga Y; Sakata M; Hayashi M; Tominaga M; Matsushita M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):520-8. PubMed ID: 22588258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
    Rajpal S; Gerovac TA; Turner NA; Tilghman JI; Allcock BK; McChesney SL; Miranpuri GS; Park SW; Resnick DK
    J Neurosurg Spine; 2007 May; 6(5):420-4. PubMed ID: 17542507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia.
    Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A
    Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
    Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
    J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
    Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
    Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of resiniferatoxin on the noxious heat threshold temperature in the rat: a novel heat allodynia model sensitive to analgesics.
    Almási R; Pethö G; Bölcskei K; Szolcsányi J
    Br J Pharmacol; 2003 May; 139(1):49-58. PubMed ID: 12746222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain.
    Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Oh SB; Lee JH
    Mol Pain; 2014 Jan; 10():2. PubMed ID: 24401144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.